BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 32513202)

  • 1. From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?
    Hanney SR; Wooding S; Sussex J; Grant J
    Health Res Policy Syst; 2020 Jun; 18(1):61. PubMed ID: 32513202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talk to Patients About: Why Will It Take So Long for a COVID-19 Vaccine?
    Price S
    Tex Med; 2020 Jun; 116(6):19. PubMed ID: 32645183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of COVID-19 vaccine development.
    Taxt AM; Grødeland G; Lind A; Müller F
    Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine development and a potential nanomaterial path forward.
    Shin MD; Shukla S; Chung YH; Beiss V; Chan SK; Ortega-Rivera OA; Wirth DM; Chen A; Sack M; Pokorski JK; Steinmetz NF
    Nat Nanotechnol; 2020 Aug; 15(8):646-655. PubMed ID: 32669664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine designers take first shots at COVID-19.
    Cohen J
    Science; 2020 Apr; 368(6486):14-16. PubMed ID: 32241928
    [No Abstract]   [Full Text] [Related]  

  • 12. Russian SARS-CoV-2 vaccine.
    Caddy S
    BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
    [No Abstract]   [Full Text] [Related]  

  • 13. A timely update of global COVID-19 vaccine development.
    Klavinskis LS; Liu MA; Lu S
    Emerg Microbes Infect; 2020 Dec; 9(1):2379-2380. PubMed ID: 33059515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Plotkin SA
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 vaccine development and the way forward.
    Arora NK; Das MK
    Indian J Public Health; 2020 Jun; 64(Supplement):S108-S111. PubMed ID: 32496238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    Trogen B; Oshinsky D; Caplan A
    JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
    [No Abstract]   [Full Text] [Related]  

  • 20. [SARS coronavirus-2 vaccines: options and state-of-the-art].
    Huckriede ALW
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.